Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

Mitf plays a key role in melanoma progression and is linked to disease stage.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

CTP-543 is generally safe for treating alopecia areata.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Matriptase imbalance contributes to cancer development and spread.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

AIMP1 can boost hair growth by increasing stem cell activity.

Enhancing Tregs can protect against alopecia areata.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.